Literature DB >> 1436492

Cloning of human neurotensin/neuromedin N genomic sequences and expression in the ventral mesencephalon of schizophrenics and age/sex matched controls.

A J Bean1, A Dagerlind, T Hökfelt, P R Dobner.   

Abstract

A human genomic clone encompassing exons 1-3 of the neurotensin/neuromedin N gene was identified using a canine neurotensin complementary DNA probe. Sequence comparisons revealed that the 120-amino acid portion of the precursor sequence encoded by exons 1-3 is 89% identical to previously determined cow and dog sequences and that the proximal 250 bp of 5' flanking sequences are strikingly conserved between rat and human. The 5' flanking sequence contains cis-regulatory sites required for the induction of neurotensin/neuromedin N gene expression in PC12 cells, including AP1 sites and two cyclic adenosine-5'-monophosphate response elements. Oligonucleotide probes based on the human sequence were used to examine the distribution of neurotensin/neuromedin N messenger RNA in the ventral mesencephalon of schizophrenics and age- and sex-matched controls. Neurotensin/neuromedin N messenger RNA was observed in ventral mesencephalic cells some of which also contained melanin pigment or tyrosine hydroxylase messenger RNA. Neurons expressing neurotensin/neuromedin N messenger RNA were observed in the ventral mesencephalon of both schizophrenic and non-schizophrenic humans.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1436492     DOI: 10.1016/0306-4522(92)90421-w

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  14 in total

1.  Characterization of promoter elements regulating the expression of the human neurotensin/neuromedin N gene.

Authors:  Xiaofu Wang; Pat Gulhati; Jing Li; Paul R Dobner; Heidi Weiss; Courtney M Townsend; B Mark Evers
Journal:  J Biol Chem       Date:  2010-10-28       Impact factor: 5.157

2.  Fetal and neoplastic expression of the neurotensin gene in the human colon.

Authors:  B M Evers; Z Zhou; V Dohlen; S Rajaraman; J C Thompson; C M Townsend
Journal:  Ann Surg       Date:  1996-05       Impact factor: 12.969

3.  Effects of neurotensin gene knockout in mice on the behavioral effects of cocaine.

Authors:  F Scott Hall; Marjorie Centeno; Maria T G Perona; Jordan Adair; Paul R Dobner; George R Uhl
Journal:  Psychopharmacology (Berl)       Date:  2011-07-01       Impact factor: 4.530

Review 4.  Cardiovascular biomarkers and sex: the case for women.

Authors:  Lori B Daniels; Alan S Maisel
Journal:  Nat Rev Cardiol       Date:  2015-07-07       Impact factor: 32.419

5.  HMC-1 human mast cells synthesize neurotensin (NT) precursor, secrete bioactive NT-like peptide(s) and express NT receptor NTS1.

Authors:  David E Cochrane; Robert E Carraway; Kimberly Harrington; Melissa Laudano; Stephen Rawlings; Ross S Feldberg
Journal:  Inflamm Res       Date:  2011-09-17       Impact factor: 4.575

6.  Developmental expression of the neurotensin gene in the rat liver.

Authors:  B M Evers; S Rajaraman; D H Chung; C M Townsend; X Wang; K Graves; J C Thompson
Journal:  Ann Surg       Date:  1993-08       Impact factor: 12.969

7.  Neuropeptides involved in the pathophysiology of schizophrenia and major depression.

Authors:  David De Wied; Hein O. Sigling
Journal:  Neurotox Res       Date:  2002 Aug-Sep       Impact factor: 3.911

8.  Expression of the neurotensin gene in fetal human liver and fibrolamellar carcinoma.

Authors:  J A Ehrenfried; Z Zhou; J C Thompson; B M Evers
Journal:  Ann Surg       Date:  1994-10       Impact factor: 12.969

9.  The neurotensin gene is a downstream target for Ras activation.

Authors:  B M Evers; Z Zhou; P Celano; J Li
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

10.  Propeptide cleavage conditions sortilin/neurotensin receptor-3 for ligand binding.

Authors:  C Munck Petersen; M S Nielsen; C Jacobsen; J Tauris; L Jacobsen; J Gliemann; S K Moestrup; P Madsen
Journal:  EMBO J       Date:  1999-02-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.